Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.
about
HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemiaExpression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurityThe mouse retina as an angiogenesis model.Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis)Roles of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase in Angiogenesis: Isoform-Specific EffectsInfluence of the difference of breastfeeding volume on a rat model of oxygen-induced retinopathy.Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells.Effect of hypoxia on expression of selected proteins involved in regulation of apoptotic activity in striatum of newborn piglets.Targeting Neovascularization in Ischemic Retinopathy: Recent AdvancesBone morphogenetic protein endothelial cell precursor-derived regulator regulates retinal angiogenesis in vivo in a mouse model of oxygen-induced retinopathy.Vascular endothelial growth factor antagonist therapy for retinopathy of prematurityMEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathyBreaking barriers: insight into the pathogenesis of neovascular age-related macular degeneration.Inner retinal oxygen metabolism in the 50/10 oxygen-induced retinopathy model.eNOS overexpression exacerbates vascular closure in the obliterative phase of OIR and increases angiogenic drive in the subsequent proliferative stageAnti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathyAnti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurityEndoplasmic reticulum stress is implicated in retinal inflammation and diabetic retinopathy.NADPH Oxidase Contributes to Photoreceptor Degeneration in Constitutively Active RAC1 Mice.Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity.The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model.Mechanotransduction drives post ischemic revascularization through K(ATP) channel closure and production of reactive oxygen species.Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.Mechanisms and management of retinopathy of prematurity.Oxidative stress in neonatology: a review.VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesisAdvances in understanding and management of retinopathy of prematurity.The protective effect of 17 beta-estradiol on oxygen-induced retinopathy and its relation with the changes of malondialdehyde.17β-estradiol ameliorates oxygen-induced retinopathy in the early hyperoxic phaseAstrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina.Ethyl pyruvate inhibits retinal pathogenic neovascularization by downregulating HMGB1 expression.VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression.Signaling pathways triggered by oxidative stress that mediate features of severe retinopathy of prematurity.The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model.The Free Radical Diseases of Prematurity: From Cellular Mechanisms to Bedside
P2860
Q28474375-5C284276-8F38-4125-9174-7B503873B5FFQ28583644-C07654D6-7210-487A-9917-6E027BE76A74Q30495106-94F2D23D-3EB9-473B-9118-D05A7D46A5A0Q33787955-474474F2-CB02-4F14-86E0-A2B908CB3EE7Q33845071-2041DA90-20A3-4754-96B0-1ED75549543AQ34292389-6385274F-0A31-44EF-A492-C66232354D1DQ34662351-D532DD27-E265-48F5-952E-05E8005F5BBAQ34765663-7B56F5B3-1FB7-4D8C-8768-B22EBC836C51Q34972210-F787B944-42D8-470E-B67F-0A4A2D72D044Q35250759-7A96C9B6-B39C-4B11-99E1-25035FBAFDD5Q35473907-6EE08976-C6E4-4574-A199-BDE4D7E60957Q36044670-10C0F2AE-32FA-4DD8-8E0C-561CBF580F7CQ36178019-58CD15D6-32A7-476B-9902-0DAEC69CB0B1Q36291702-62C082A7-49D5-4235-B2D0-4935852996DFQ36302954-9AFCDC48-42DA-4AAB-A943-6D054F49701AQ36379513-5B21CD1F-A4D4-48C2-9C03-641AE3AA1D55Q36752978-3C02719A-716D-4011-80C7-D36168BE419CQ37214899-C4B386D0-D7F0-4B0E-A31A-3F40261AF736Q37420843-7BC7A6B4-A132-453B-9E42-9BC8B4107A0DQ37561227-48A60DEB-9DAC-4584-A293-ACD73F971463Q37565247-E65D502A-E950-4A38-9A9B-400F8A58737BQ37584923-ABB4084D-7B62-4D16-B6FB-54C0414A8219Q37623450-E4D78FB9-CFD1-426F-9A2D-3F4D3A1A6133Q38069895-CF6EEC7D-D79C-44CD-8525-0CAF87C081BBQ38151240-BF8386EF-CF39-4690-88E7-B627D47654F6Q38560836-45206027-D77F-4387-AFD3-CA108BF2A61BQ39052915-AD6D9E48-939C-4E5C-B9E8-7CCE2978FF37Q41169875-72C068A1-89F2-4DB3-8FB1-5C92CA7FF008Q41205833-93E2545C-75B8-4C4A-AE2A-6FBBB9D7ED72Q41457604-555EA595-7474-4825-B23E-598A914E1B39Q41864669-24ADAD68-30A5-499C-8AB3-CCD39C6B5701Q42044757-CDC5659E-6572-45FC-A675-F72E35F07628Q42081421-E94DBC43-A073-4D80-9E95-29C176FA172DQ42155684-0FEECF34-81E9-40CC-8931-DEBBDB3F5E9EQ58188912-86F4A4E7-AFD2-4FEC-96B1-BD2F4FD13720
P2860
Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Activated NAD(P)H oxidase from ...... inopathy of prematurity model.
@ast
Activated NAD(P)H oxidase from ...... inopathy of prematurity model.
@en
type
label
Activated NAD(P)H oxidase from ...... inopathy of prematurity model.
@ast
Activated NAD(P)H oxidase from ...... inopathy of prematurity model.
@en
prefLabel
Activated NAD(P)H oxidase from ...... inopathy of prematurity model.
@ast
Activated NAD(P)H oxidase from ...... inopathy of prematurity model.
@en
P2093
P2860
P356
P1476
Activated NAD(P)H oxidase from ...... inopathy of prematurity model.
@en
P2093
Abhineet Uppal
Grace Byfield
M Elizabeth Hartnett
Steven Budd
Yuta Saito
P2860
P304
P356
10.1167/IOVS.07-1356
P407
P577
2008-04-01T00:00:00Z